Online citations, reference lists, and bibliographies.
← Back to Search

Prenatal Screening For Major Congenital Heart Disease: Assessing Performance By Combining National Cardiac Audit With Maternity Data

H. Gardiner, A. Kovacevic, L. B. van der Heijden, P. Pfeiffer, R. Franklin, J. Gibbs, I. Averiss, J. Larovere
Published 2013 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Objective Determine maternity hospital and lesion-specific prenatal detection rates of major congenital heart disease (mCHD) for hospitals referring prenatally and postnatally to one Congenital Cardiac Centre, and assess interhospital relative performance (relative risk, RR). Methods We manually linked maternity data (3 hospitals prospectively and another 16 retrospectively) with admissions, fetal diagnostic and surgical cardiac data from one Congenital Cardiac Centre. This Centre submits verified information to National Institute for Cardiovascular Outcomes Research (NICOR-Congenital), which publishes aggregate antenatal diagnosis data from infant surgical procedures. We included 120 198 unselected women screened prospectively over 11 years in 3 maternity hospitals (A, B, C). Hospital A: colocated with fetal medicine, proactive superintendent, on-site training, case-review and audit, hospital B: on-site training, proactive superintendent, monthly telemedicine clinics, and hospital C: sonographers supported by local obstetrician. We then studied 321 infants undergoing surgery for complete transposition (transposition of the great arteries (TGA), n=157) and isolated aortic coarctation (CoA, n=164) screened in hospitals A, B, C prospectively, and 16 hospitals retrospectively. Results 385 mCHD recorded prospectively from 120 198 (3.2/1000) screened women in 3 hospitals. Interhospital relative performance (RR) in Hospital A:1.68 (1.4 to 2.0), B:0.70 (0.54 to 0.91), C:0.65 (0.5 to 0.8). Standardised prenatal detection rates (funnel plots) demonstrating inter-hospital variation across 19 hospitals for TGA (37%, 0.00 to 0.81) and CoA (34%, 0.00 to 1.06). Conclusions Manually linking data sources produced hospital-specific and lesion-specific prenatal mCHD detection rates. More granular, rather than aggregate, data provides meaningful feedback to improve screening performance. Automatic maternal and infant record linkage on a national scale, requires verified, prospective maternity audit and integration of health information systems.
This paper references
Working Paper 6
Frederick O. Gearing (1979)
Secretaries of State for Health, Wales, Northern Ireland and Scotland. Medical audit. Working paper 6
(1989)
10.1016/S0140-6736(99)01167-8
Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK
C. Bull (1999)
10.1046/J.1469-0705.2001.00414.X
Examination of the fetal heart by five short‐axis views: a proposed screening method for comprehensive cardiac evaluation
S. Yagel (2001)
10.1136/BMJ.38027.613403.F6
Survival after surgery or therapeutic catheterisation for congenital heart disease in children in the United Kingdom: analysis of the central cardiac audit database for 2000-1
J. Gibbs (2004)
10.1136/bmj.38300.665301.3A
Congenital anomaly surveillance in England—ascertainment deficiencies in the national system
P. Boyd (2004)
10.1136/hrt.2005.078097
Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates
K. Brown (2006)
10.1136/BMJ.333.7572.774
North-south divide in health persists in England
Z. Kmietowicz (2006)
10.1136/adc.2007.119032
Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations
C. Wren (2007)
10.1002/pbc.21682
Congenital anomaly and childhood cancer: A population‐based, record linkage study
J. Rankin (2008)
10.1136/hrt.2010.206623
Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience
J. Marek (2010)
10.1016/S0140-6736(11)61229-4
Telemedicine and remote management of patients with heart failure
S. Anker (2011)
10.1258/jms.2011.010139
Monitoring the Prenatal Detection of Structural Fetal Congenital Anomalies in England and Wales: Register-based Study
P. Boyd (2011)
10.1016/J.YOBG.2011.06.022
Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience
L. Shulman (2011)
Report on the evaluation of the Regional Obstetric Ultrasound Coordinator’s (ROSCO) role
A. Butler (2011)
10.1002/pd.3926
A fetal telecardiology service: patient preference and socio‐economic factors
B. McCrossan (2012)
10.1093/ije/dys064
Cohort Profile: The ‘Children of the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children
A. Boyd (2013)
10.1258/jtt.2012.120418
The Cost-Effectiveness of Prenatal Detection for Congenital Heart Disease Using Telemedicine Screening
H. Mistry (2013)
Cohort pro fi le : the ‘ children of the 90 s ’ — the index offspring of the avon longitudinal study of parents and children
PA Boyd (2013)
Delayed diagnosis of congenital
KL Brown



This paper is referenced by
10.3390/jcm10153423
Fetal Cardiac Services during the COVID-19 Pandemic: How Does It Affect Parental Counseling?
A. Kovacevic (2021)
10.3390/diagnostics11071185
Can Fetal Echocardiographic Measurements of the Left Ventricular Outflow Tract Angle Detect Fetuses with Conotruncal Cardiac Anomalies?
A. Raucher Sternfeld (2021)
10.1017/S104795112000476X
Global Leadership in Paediatric and Congenital Cardiac Care: “Coding our way to improved care: an interview with Rodney C. G. Franklin, MBBS, MD, FRCP, FRCPCH”
Justin T. Tretter (2021)
10.1016/j.cjco.2021.06.008
The Mathematical Limitations of Fetal Echocardiography as a Screening Tool in the Setting of a Normal Second-Trimester Ultrasound
Samuel Bellavance (2021)
10.1016/j.cjca.2020.01.010
Prenatal Diagnosis of Transposition of the Great Arteries Reduces Postnatal Mortality: A Population-Based Study.
H. Nagata (2020)
10.1007/978-3-030-24174-2_99
Transposition of the Great Arteries
E. Frandsen (2020)
10.14260/jemds/2020/233
Pulse Oximetry a Non-Invasive Screening Test to Intensify Primary Diagnosis of Critical Cyanotic Congenital Heart Disease in Neonates- A Retrospective Study
S. Nirala (2020)
10.3389/fped.2020.00026
Counseling for Prenatal Congenital Heart Disease—Recommendations Based on Empirical Assessment of Counseling Success
A. Kovacevic (2020)
10.1177/2150135119882927
Prenatal Detection—The Real Oxygen of Success?
H. Gardiner (2019)
10.1136/heartjnl-2019-315287
Tricuspid regurgitation severity after atrial septal defect closure or pulmonic valve replacement
A. Martín-García (2019)
10.1080/01443615.2019.1621814
The accuracy of prenatal diagnosis of major congenital heart disease is increasing
R. Lytzen (2019)
10.1016/j.jogc.2018.10.009
Rationale and Design of the FREQUENCY Study: The Fetal Cardiac Registry of Québec to Improve Resource Utilization in Fetal Cardiology.
Camille Noël (2019)
10.1136/wjps-2019-000051
Screening for congenital heart defects: diversified strategies in current China
Xiwang Liu (2019)
10.1002/jum.15157
Is Fetal Intelligent Navigation Echocardiography Helpful in Screening for d‐Transposition of the Great Arteries?
Chao Huang (2019)
10.1111/apa.14946
Newborn pulse oximetry screening in the context of a high antenatal detection rate of critical congenital heart disease
E. Cloete (2019)
10.1007/s00246-019-02155-7
Fetal Echocardiographic Parameters and Surgical Outcomes in Congenital Left-Sided Cardiac Lesions
Lindsay A. Edwards (2019)
10.1055/s-0039-1691773
Updates in Congenital Heart Disease: Can Outcomes Improve?
G. Martin (2019)
10.1136/archdischild-2018-315887
Congenital left heart obstruction: ethnic variation in incidence and infant survival
E. Cloete (2019)
Nutritional status and its relationship with infection-related complications in children after cardiac surgery
R. Hill (2019)
10.1002/jum.15199
Physician Barriers and Facilitators for Screening for Congenital Heart Disease With Routine Obstetric Ultrasound
N. Pinto (2019)
10.1016/j.siny.2017.11.006
Advances in fetal echocardiography.
H. Gardiner (2018)
10.1002/uog.17496
Population trends in prenatal detection of transposition of great arteries: impact of obstetric screening ultrasound guidelines
P. Ravi (2018)
10.1001/jamacardio.2018.2009
Live-Born Major Congenital Heart Disease in Denmark: Incidence, Detection Rate, and Termination of Pregnancy Rate From 1996 to 2013
R. Lytzen (2018)
10.1055/a-0633-3331
Assessment of Needs for Counseling After Prenatal Diagnosis of Congenital Heart Disease - A Multidisciplinary Approach.
A. Kovacevic (2018)
Prenatal diagnosis of congenital heart disease
Mrcpch (2018)
10.1530/ERP-18-0027
EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Prenatal diagnosis of congenital heart disease
L. Hunter (2018)
10.1177/8756479316677019
Sonographer-Identified Barriers and Facilitators to Prenatal Screening for Congenital Heart Disease
N. Pinto (2017)
10.1016/j.amjcard.2017.01.017
Usefulness of the Prenatal Echocardiogram in Fetuses With Isolated Transposition of the Great Arteries to Predict the Need for Balloon Atrial Septostomy.
T. Vigneswaran (2017)
10.1007/s00246-017-1739-x
Hypertension in Coarctation of the Aorta: Challenges in Diagnosis in Children
T. Vigneswaran (2017)
10.4137/CMPed.S33086
Universal Pulse Oximetry Screening for Early Detection of Critical Congenital Heart Disease
Praveen Kumar (2016)
10.1007/s40124-016-0095-2
An Update on Critical Congenital Heart Disease Screening Using Pulse Oximetry
Lisa A Hom (2016)
10.1016/j.ejogrb.2016.06.008
Prenatal detection of major congenital heart disease - optimising resources to improve outcomes.
S. Corcoran (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar